Please wait while the formulary information is being retrieved.
VASOSTRICT (VASOPRESSIN)
- Hypotension due to distributive shock
20 unit/mL intravenous solution
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Uremia
Contraindicated
- Coronary artery disease
- Hypertension
Severe
Moderate
- Asthma
- Heart failure
- Migraine
- Seizure disorder
VASOSTRICT (VASOPRESSIN)
- Hypotension due to distributive shock
- None
- None
More Frequent
Severe
Less Severe
- None
- Abdominal pain with cramps
- Diarrhea
- Dizziness
- Eructation
- Flatulence
- Headache disorder
- Hyperhidrosis
- Mouth discoloration
- Nausea
- Pallor
- Tenesmus
- Tremor
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute myocardial infarction
- Allergic dermatitis
- Angina
- Angioedema
- Atrial fibrillation
- Bradycardia
- Dyspnea
- Hemorrhage
- Hyperbilirubinemia
- Hyponatremia
- Low cardiac output
- Peripheral ischemia
- Pruritus of skin
- Skin rash
- Thrombocytopenic disorder
- Urticaria
- Water intoxication
- Wheezing
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Vasopressin
Risk of hyponatremia and water intoxication. Monitor fluid intake.
- 1 Day – 13 Years
- Risk of hyponatremia and water intoxication. Monitor fluid intake.
Vasopressin
- Severity Level:
C
- Additional Notes: Caution recommended by mfg; possible oxytocic effect
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
Vasopressin
Quickly destroyed in gi tract;Unlikely clinically signif amt absorbed by inf
General | Excretion Potential | Effect on Infant | Notes |
No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Quickly destroyed in gi tract;Unlikely clinically signif amt absorbed by inf |
Contraindicated
None
Precaution Exists
Vasopressin
Risk of water intoxication and hyponatremia.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | N | N | N | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
Hypotension due to distributive shock | |
A48.3 | Toxic shock syndrome |
E27.2 | Addisonian crisis |
I95 | Hypotension |
R65.21 | Severe sepsis with septic shock |
T78.2 | Anaphylactic shock, unspecified |
T78.2xxA | Anaphylactic shock, unspecified, initial encounter |
T81.12 | Postprocedural septic shock |
T81.12xA | Postprocedural septic shock, initial encounter |
0-9 | A-Z |
---|---|
A48.3 | Toxic shock syndrome |
E27.2 | Addisonian crisis |
I95 | Hypotension |
R65.21 | Severe sepsis with septic shock |
T78.2 | Anaphylactic shock, unspecified |
T78.2xxA | Anaphylactic shock, unspecified, initial encounter |
T81.12 | Postprocedural septic shock |
T81.12xA | Postprocedural septic shock, initial encounter |
Formulary Reference Tool